XFRA : 8XB: Aussetzung/Suspension
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME …
0,260€
Echtzeit-Aktienkurs BIOCARTIS GR. 144A/REG S
Bid:
Ask:
Nachrichten zur BIOCARTIS GR. 144A/REG S Aktie
XFRA : INSTRUMENT_SUSPENSION - BE0974281132
Instrument ID [1389] (8XB - BE0974281132) suspended...…
Press release Biocartis Group NV: Expected Mandatory Conversion Bondholder Notification
PRESS RELEASE: REGULATED INFORMATION...…
Press release Biocartis Group NV: Biocartis launches a rights offering (with extra-legal preferential rights for existing shareholders) of a maximum of 33,476,932 offered shares, amounting to a maximum of EUR 25,107,699.00
ADVERTISEMENT...…
Press release Biocartis Group NV: New Idylla™ EGFR Study Shows Reduction of Time-to-Treatment by 48% for Lung Cancer Patients
PRESS RELEASE: 8 November 2022, 07:00 CET...…
Press release Biocartis Group NV: Biocartis Announces Nine Idylla™ Studies to be Published at Upcoming AMP 2022 Annual Meeting
PRESS RELEASE: 31 October 2022, 17:40 CET...…
Press release Biocartis Group NV: Biocartis Announces Completion of Exchange Offer for its Existing Convertible Bonds, and issuance of New Convertible Bonds
PRESS RELEASE: REGULATED INFORMATION...…
Press release Biocartis Group NV: Biocartis Announces Conversion of a Portion of the Convertible Term Loan into New Shares and Discloses Outstanding Voting Securities
PRESS RELEASE: REGULATED INFORMATION ...…
Press release Biocartis Group NV: Biocartis Reports Results of Third Quarter of 2022
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA…
Press release Biocartis Group NV: Biocartis Announces First Drawdown of New Convertible Term Loans
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA…
Press release Biocartis Group NV: Biocartis Announces Successful Amendment of its Existing Convertible Bonds
PRESS RELEASE: INSIDE INFORMATION / REGULATED INFORMATION...…
Press news Biocartis Group NV: Biocartis Initiates Commercialization in Europe of HepatoPredict (CE-IVD) Test for Liver Cancer Patients
PRESS RELEASE: 10 October 2022, 07:00 CEST...…